Received Aug 8, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTPPVHBHPB | DTAP+IPV+HIB+HEPB (VAXELIS) | MSP VACCINE COMPANY | UNK | U7829AA | — |
| PNC15 | PNEUMO (VAXNEUVANCE) | MERCK & CO. INC. | UNK | Z003633 | — |
| RV1 | ROTAVIRUS (ROTARIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | — | OT |
No other AE; HCP calling to report the inadvertent administration of a VAXNEUVANCE and VAXELIS dose to a patient prior to the recommended age. Caller states this patient also received the ROTARIX Vaccine on the same day. No symptoms reported as of yet and no ad; This spontaneous report was received from an Other health professional and refers to a 6-day-old female patient. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On an unknown date, the patient was vaccinated with Pneumococcal 15-valent Conjugate Vaccine (VAXNEUVANCE) lot #Z003633, which was confirmed to be a valid lot#, expiration date: 24-May-2027 (dose, units and route of administration were not reported) for prophylaxis. On the same day, the patient was vaccinated with Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed, Inactivated Poliovirus, ... (VAXELIS) lot #U7829AA, which was confirmed to be a valid lot#, expiration date: 14-Jul-2026, (dose, units and route of administration were not reported) for prophylaxis. Also on the same day, the patient was vaccinated with Rotarix (Rotavirus vaccine live oral 1v) administered by Oral route (lot # and expiration date were not reported) for prophylaxis. It was reported that the vaccines were administered inadvertently to the patient prior to the recommended age (Product administered to patient of inappropriate age). There were no symptoms reported, and no additional details provided (No adverse event).; Reporter's Comments: